Features Partner Sites Information LinkXpress
Sign In
Demo Company

New Line of Laboratory Balances Focuses on Most Often Used Weighing Tasks

By BiotechDaily International staff writers
Posted on 08 May 2014
Print article
Image: Some examples of the new Entris line of laboratory balances (Photo courtesy of Sartorius).
Image: Some examples of the new Entris line of laboratory balances (Photo courtesy of Sartorius).
Biotech and other life science researchers can increase their productivity by selecting one or more new laboratory balances from an innovative new line.

Sartorius (Gottingen, Germany) recently introduced the new Entris, a balance that focuses on the most commonly used weighing applications and dispenses with costly additional functions.

The line of Entris balances comprised 15 analytical and precision balances that cover a weighing capacity from 60 grams to 8.2 kilograms with a readability of 0.1 milligram to 0.1 gram.

The logical key assignment on the Entris and its clearly structured user interface make daily routine weighing much easier. Most models of the new Entris family are equipped with a monolithic weighing system featuring external adjustment or an internal, motorized adjustment function. This guarantees consistently accurate weighing results, which are displayed on the easy-to-read backlit, high-contrast display.

The Entris system, which can display information in German, English, French, Italian, Spanish, Russian and Polish, is equipped with applications for density determination, animal weighing, counting, conversion, and weighing in percent. The easily removable draft shield and stainless steel parts render the Entris quick and easy to clean.

Related Links:

Print article



view channel
Image: Left: Green actin fibers create architecture of the cell. Right: With cytochalasin D added, actin fibers disband and reform in the nuclei (Photo courtesy of the University of North Carolina).

Actin in the Nucleus Triggers a Process That Directs Stem Cells to Mature into Bone

A team of cell biologists has discovered why treatment of mesenchymal stem cells (MSCs) with the mycotoxin cytochalasin D directs them to mature into bone cells (osteoblasts) rather than into fat cells... Read more


view channel

Molecular Light Shed on “Dark” Cellular Receptors

Scientists have created a new research tool to help find homes for orphan cell-surface receptors, toward better understanding of cell signaling, developing new therapeutics, and determining causes of drug side-effects. The approach may be broadly useful for discovering interactions of orphan receptors with endogenous, naturally... Read more

Lab Technologies

view channel
Image: The new ambr 15 fermentation micro-bioreactor system was designed to enhance microbial strain screening applications (Photo courtesy of Sartorius Stedim Biotech).

New Bioreactor System Streamlines Strain Screening and Culture

Biotechnology laboratories working with bacterial cultures will benefit from a new automated micro bioreactor system that was designed to enhance microbial strain screening processes. The Sartorius... Read more


view channel

Purchase of Biopharmaceutical Company Will Boost Development of Nitroxyl-Based Cardiovascular Disease Drugs

A major international biopharmaceutical company has announced the acquisition of a private biotech company that specializes in the development of drugs for treatment of cardiovascular disease. Bristol-Myers Squibb Co. (New York, NY, USA) has initiated the process to buy Cardioxyl Pharmaceuticals Inc. (Chapel Hill, NC, USA).... Read more
Copyright © 2000-2015 Globetech Media. All rights reserved.